HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ubiquitination of alpha-synuclein filaments by Nedd4 ligases.

Abstract
Alpha-synuclein can form beta-sheet filaments, the accumulation of which plays a key role in the development of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. It has previously been shown that alpha-synuclein is a substrate for the HECT domain-containing ubiquitin ligase Nedd4, and is subject to ubiquitin-mediated endosomal degradation. We show here that alpha-synuclein filaments are much better substrates for ubiquitination in vitro than monomeric alpha-synuclein, and that this increased susceptibility cannot be mimicked by the mere clustering of monomers. Recognition by Nedd4 family enzymes is not through the conventional binding of PPxY-containing sequences to WW domains of the ligase, but it also involves C2 and HECT domains. The disease-causing alpha-synuclein mutant A53T is a much less efficient substrate for Nedd4 ligases than the wild-type protein. We suggest that preferential recognition, ubiquitination and degradation of beta-sheet-containing filaments may help to limit toxicity, and that A53T alpha-synuclein may be more toxic, at least in part because it avoids this fate.
AuthorsThomas Mund, Masami Masuda-Suzukake, Michel Goedert, Hugh R Pelham
JournalPloS one (PLoS One) Vol. 13 Issue 7 Pg. e0200763 ( 2018) ISSN: 1932-6203 [Electronic] United States
PMID30021006 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • alpha-Synuclein
  • Nedd4 Ubiquitin Protein Ligases
  • Nedd4 protein, human
Topics
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Nedd4 Ubiquitin Protein Ligases (metabolism)
  • Protein Binding
  • Ubiquitination (genetics, physiology)
  • alpha-Synuclein (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: